TABLE 6.
Ingredient | In vivo/In vitro | Model | Administration | Dose/Time | Treatment effect | Mechanism | Diseases | References |
---|---|---|---|---|---|---|---|---|
Salvia miltiorrhiza injection | In vivo | Rabbit model of avascular necrotic femoral head | Injection | 2 mL for 3 weeks and 6 weeks | Promote vascular recanalization by increasing the expression of VEGF and BMP-2 in femoral vein head | - | ONFH | Wu et al. (2019) |
Salvianolic acid B | In vivo | Steroid-induced osteonecrosis of the femoral head in rats | Injection | 40 mg/kg/d for 3 weeks | Increase the expression levels of Runx2 and Col-I | Inhibit the expression levels of PPARγ and AP2 proteins | ONFH | Li and Wang (2017) |
TanshinoneⅠ | In vivo | Steroid-induced osteonecrosis of the femoral head rats | Intraperitoneal injection | 5, 10 mg/kg/d for 4 weeks | Increase alkaline phosphatase activity and expressions of osteoblastic markers including OCN, Col-I, OPN, and Runx2 and decreased TRAP and expressions of osteoclastic markers including cathepsin K and acid phosphatase 5 | Activate the Nrf2 Signaling Pathway | SIONFH | Xu et al. (2021) |
Note: ON-FH, osteonecrosis of the femoral head; SIONFH, steroid-induced femoral head necrosis; VEGF, Vascular endothelial growth factor; BMP-2, bone morphogenetic protein-2; Runx2, Runt-related transcription factor 2; Col-I, type I collagen protein; OCN, Ostecalcin; OPN, Osteopontin; TRAP, Tartrate resistant acid phosphatase; (PPAR)γ, peroxisome proliferator-activated receptor; AP2, Adipocyte protein 2.